Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000819992 | SCV000960684 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001759603 | SCV002007774 | uncertain significance | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002537454 | SCV003730171 | uncertain significance | Inborn genetic diseases | 2022-11-18 | criteria provided, single submitter | clinical testing | The c.1985A>G (p.H662R) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a A to G substitution at nucleotide position 1985, causing the histidine (H) at amino acid position 662 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |